Discover What's
Next in
Cardiovascular Care.
Experience breakthrough Nanolute™ sirolimus-coated balloon technology — backed by landmark NEJM and JACC publications. Meet our experts at Booth F18, Paris.
Join Our Symposium
Deep dive into a session on sirolimus-coated balloon evidence and real-world procedural experience featuring global faculty with expert case discussions.
Where Evidence Meets Experience
Revolutionizing Drug Delivery in Vascular Intervention
NANOLUTE technology delivers polymer-free nanocarriers containing sirolimus surrounded by an encapsulation of a proprietary phospholipid carrier — improving lipophilicity and ensuring deep vessel wall penetration.
- Facilitates better adhesion of Sirolimus on the balloon surface
- Circumferential coating ensures homogeneous drug delivery
- Effective drug transfer to the deepest layer of the vessel
- Better in-tissue bioavailability of Sirolimus
A Decade
of Evidence
From CE Mark to a still-growing clinical record.
19 Clinical trials · 9,000+ patients · 30+ publications.
MagicTouch
It's repeatedly studied.
Landmark Clinical Results
Randomised controlled trials demonstrating superior outcomes across coronary and peripheral indications — from JACC to the New England Journal of Medicine.
Meet Our Experts
at Booth F18
Schedule time with our clinical and commercial team for a personalised demo, data review, or strategic discussion.